---
category: listing
circular_id: 5cbd7a469cdc006b
date: '2025-10-10'
description: Listing of 13,33,332 equity shares of Vivo Bio tech Ltd. issued on preferential
  basis pursuant to conversion of warrants, effective October 13, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={97E28E21-CDDD-49E2-9AF8-6B70CAB47214}&noticeno=20251010-25&dt=10/10/2025&icount=25&totcount=72&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine listing of shares from warrant conversion for a single company
  with lock-in restrictions, limited market-wide impact
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251010-25&attachedId=
processing:
  attempts: 1
  content_hash: 52578479c0827ed3
  processed_at: '2025-10-10T18:48:48.379823'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-10-10T11:26:20+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={97E28E21-CDDD-49E2-9AF8-6B70CAB47214}&noticeno=20251010-25&dt=10/10/2025&icount=25&totcount=72&flag=0
severity: low
source: bse
stocks:
- VIVOBIOTECH
tags:
- listing
- equity-shares
- preferential-issue
- warrant-conversion
- vivo-bio-tech
title: Listing of New Securities of Vivo Bio tech Ltd.
---

## Summary

Vivo Bio tech Ltd. (Scrip Code: 511509) will list 13,33,332 new equity shares on BSE effective Monday, October 13, 2025. These shares were issued at Rs. 45/- per share (face value Rs. 1/- with premium of Rs. 35/-) to Non-Promoters on a preferential basis pursuant to conversion of warrants. The shares rank pari-passu with existing equity shares and are subject to lock-in restrictions.

## Key Points

- Total shares listed: 13,33,332 equity shares of Rs. 1/- each
- Issue price: Rs. 45/- per share (Rs. 1/- face value + Rs. 35/- premium)
- Allotted to: Non-Promoters on preferential basis
- Basis: Conversion of warrants
- Distinctive numbers: 19999890 to 21333221
- Date of allotment: August 12, 2025
- Trading commencement: October 13, 2025
- ISIN: INE380K01017
- Ranking: Pari-passu with existing equity shares

## Regulatory Changes

No regulatory changes announced. This is a standard listing notification for new securities.

## Compliance Requirements

- Trading members must note the listing of these new securities
- All 13,33,332 shares (Dist. Nos. 19999890 to 21333221) are subject to lock-in until April 30, 2025
- Shares cannot be traded or transferred during the lock-in period except as per SEBI regulations

## Important Dates

- **Date of Allotment**: August 12, 2025
- **Trading Commencement**: October 13, 2025 (Monday)
- **Lock-in Expiry**: April 30, 2025
- **Notice Date**: October 10, 2025

## Impact Assessment

**Market Impact**: Low - This is a routine listing of shares from warrant conversion for a single company. The shares represent a preferential allotment to non-promoters.

**Operational Impact**: Minimal - Trading members need to be aware of the new shares and their lock-in restrictions. The lock-in period extends until April 30, 2025, limiting immediate tradability.

**Investor Impact**: The listing increases the total issued capital of Vivo Bio tech Ltd. The shares issued to non-promoters may affect ownership structure but are locked in until April 2025, preventing immediate market dilution.

**Notice Details**: Notice No. 20251010-25, Category: Company related, Segment: Equity, issued by Kinnar Mehta, Assistant Vice President, BSE.